Our Vaccine Trials
Phase 1 study to Investigate the Safety and Immunogenicity of a Combined Respiratory Syncytial Virus/human Metapneumovirus/Parainfluenza Virus type 3 investigational mRNA Vaccine Candidate in Adult Participants Aged 60 Years and Older.
This study is being conducted at our Central Coast, Brisbane and Western Sydney sites.
Apply NowA Phase 1 study to investigate the safety and immunogenicity of an adjuvanted RSV/hMPV mRNA vaccine in adult participants aged 60 to 75 years.
This study is being conducted at our Brisbane site.
Apply NowThis study is researching whether an investigational vaccine is safe, well-tolerated and is able to protect against norovirus gastroenteritis, a virus that can cause gastro.
This study is being conducted at our Brisbane, Central Coast and Canberra sites.
Apply Now